Pathogenesis and prevention of graft-versus-host disease
- 1 September 2001
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 6 (3), 265-271
- https://doi.org/10.1097/00075200-200109000-00012
Abstract
No abstract availableThis publication has 83 references indexed in Scilit:
- A Fas-based suicide switch in human T cells for the treatment of graft-versus-host diseaseBlood, 2001
- TUMOR NECROSIS FACTOR-?? NEUTRALIZATION REDUCES LUNG INJURY AFTER EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION1Transplantation, 2000
- BACTERIAL TRANSLOCATION DURING GRAFT-VERSUS-HOST DISEASE AFTER SMALL BOWEL TRANSPLANTATION IS REDUCED FOLLOWING INHIBITION OF INDUCIBLE NITRIC OXIDE SYNTHESIS1,2Transplantation, 2000
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- CTLA-4 and T cell activationCurrent Opinion in Immunology, 1999
- The Effect of Graft-versus-Host Disease on T Cell Production and HomeostasisThe Journal of Experimental Medicine, 1999
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- Regulation of interferon-γ production by IL-12 and IL-18Current Opinion in Immunology, 1998
- T cell clonal anergyCurrent Opinion in Immunology, 1997
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994